| IRI | immunoreactive insulin; insulin resistance index |
|---|---|
| IRS | immunoreactive secretion; infrared spectrophotometry; insulin receptor species; insulin receptor sub... |
| IST | inappropriate sinus tachycardia; insulin sensitivity test; insulin shock therapy; International Soci... |
| FTND | Full-Term Normal Delivery; 만기정상분만(滿期正常分娩) |
| ADFS | alternative delivery and financing system |
| delivery rooms | Hospital units equipped for childbirth. (12 Dec 1998) |
|---|---|
| delivery system | A manmade system with the purpose of delivering a drug or another chemical directly into a cellular target, such as a via a manmade vesicle called a liposome. (09 Oct 1997) |
| delivery, vertex | In a vertex delivery, the top of the baby's head comes first. The vertex here refers to the top of the head The word vertex in Latin means a whirlpool, whirlwind, top of the mountain, or the top of the head. Why top of the head ? Because the hairs on the top of the head often form a whorl, a whirl-like pattern. (12 Dec 1998) |
| drug delivery | The method and route used to provide medication. (16 Dec 1997) |
| drug delivery systems | Systems of administering drugs through controlled delivery so that an optimum amount reaches the target site. Drug delivery systems encompass the carrier, route, and target. (12 Dec 1998) |
| outlet forceps delivery | Delivery by forceps applied to the foetal head when it has reached the perineal floor and is visible between contractions. (05 Mar 2000) |
| targeted drug delivery | Delivering a drug to a specific site in the body where it has the greatest effect, instead of allowing it to diffuse to various sites, where it may cause damage or trigger side effects. (14 Nov 1997) |
| forceps delivery | Assisted birth of the child by an instrument designed to grasp the foetal head. (05 Mar 2000) |
| low forceps delivery | Delivery by forceps applied to the foetal head after it is clearly visible, the skull has reached the perineal floor, and plus 2 (+2) station. This classification of forceps delivery may be with or without rotation of the foetal head. (05 Mar 2000) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| anti-insulin | A factor, usually an antibody, which antagonises the action of insulin. (05 Mar 2000) |
| anti-insulin antibody | A serologic blood test that is used to detect antibodies to insulin. This test is performed in insulin dependent diabetics who exhibit insulin resistance. The presence of antibodies denotes a positive result. (27 Sep 1997) |
| biphasic insulin | <protein> A type of insulin that is a mixture of intermediate- and fast-acting insulin. (09 Oct 1997) |
| receptors, insulin | Cell surface proteins that bind insulin and trigger intracellular changes which influence the behaviour of cells. The best understood physiological consequence of insulin receptor activation is increased transport of glucose into most cells, which controls the rate of carbohydrate metabolism. The insulin receptor is a multifunctional protein complex that has intrinsic tyrosine kinase activity and is capable of autophosphorylation. (12 Dec 1998) |
| receptors, insulin-like-growth factor I | Specific proteins on or in cells to which insulin-like growth factor I (somatomedin c) binds and thereby modifies the function of the cells. These receptors contain transmembrane and cytosolic domains, bind igf-I preferentially, and have high-affinity sites for igf-II. The alpha-subunit has a mw of 130 kD and the beta subunit possesses tyrosine kinase activity. (12 Dec 1998) |